A Narrative Review on Dialectical Behavior Therapy for Patients with Depressive Difficulties

2021 ◽  
Vol 18 ◽  
Author(s):  
Aryendu Kumar Saini ◽  
Pranay Wal ◽  
Ankita Wal ◽  
Rashmi Saxena Pal ◽  
Om Prakash Verma
Keyword(s):  
Behavior Therapy ◽  
Dialectical Behavior Therapy ◽  
Behavioral Therapy ◽  
Controlled Trial ◽  
Psychological Disorders ◽  
Borderline Personality ◽  
Randomized Controlled ◽  
Long Term Effect

Background: Dialectical behavior therapy (DBT) is a type of cognitive behavioral therapy (CBT) that was earlier intended to treat only patients with borderline personality disorder (BPD), but researchers have found DBT to treat several psychological disorders, including depression. Aim: The article aims to review the clinical shreds of evidence regarding the use of DBT to treat depression. Methods: PubMed literature search was done by applying the year filter range, 2010 to 2021. Another filter applied was "Randomized controlled trial", so that the strength of evidence could be enhanced. The keywords used were "Dialectical Behavior Therapy" AND "Depression Results: 33 articles were found, out of which only 20 relevant articles were reviewed. DBT was found to alleviate depressive symptoms associated with different psychological disorders like bipolar disorder and BPD but the number of studies that validated the afore-mentioned were less than those studies which showed that DBT had no significant effect on the patients with depressive difficulties. The long-term effect of DBT for treating depression is under a suspect, as studies showed DBT got ineffective during the follow-ups Conclusion: DBT shows benefits in depression but further studies are still required to validate this concretely as DBT did not show a significant effect when compared to its control counterparts. There is much need for future studies which can evaluate the long-term efficacy of DBT in depression is another challenging area because follow-up data did not favor DBT.

scholarly journals Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial

2021 ◽  
Vol 8 ◽  
Author(s):  
Hao Sun ◽  
Bing Ma ◽  
Xiaomei Wu ◽  
Hailong Wang ◽  
Bo Zhou
Keyword(s):  
Randomized Controlled Trial ◽  
Sodium Salt ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Low Sodium ◽  
Long Term Effect ◽  
Salt Substitute ◽  
Cvd Mortality

Background: Salt substitute, a strategy for salt reduction, has been shown to decrease blood pressure and the incidence of hypertension. However, whether its hypotensive effect will reduce long-term mortality remains unclear. Our study reported an exploratory follow-up of mortality outcomes from previous randomized controlled trial to assess the long-term effect of low-sodium salt on total and cardiovascular disease (CVD) mortality.Methods: Participants who completed a previous 3-year double-blind randomized controlled trial were followed up from 2009 to 2019 to collect mortality data. Multivariable Cox regression models were used to evaluate the association between low-sodium salt intervention and all-cause and CVD mortality.Results: Four hundred and forty participants completed the intervention trial, of which 428 participants had death outcome data recorded after 10 years follow-up: 209 in a salt substitute group and 219 in a normal salt group. Fifty participants died during follow-up, 25 died due to CVD. No significant differences in relative risks were found for all-cause mortality [HR = 0.81, 95% confidence interval (CI): 0.46–1.42] and CVD mortality (HR = 0.58, 95% CI: 0.26–1.32) in unadjusted analyses. After adjusted with age and alcohol drinking status, there were significant reductions for stroke mortality among all participants (HR = 0.26, 95% CI: 0.08–0.84) and for CVD mortality (HR = 0.38, 95% CI: 0.16–0.92) and stroke mortality (HR = 0.25, 95% CI: 0.08–0.82) among hypertensive participants.Conclusions: Compared to normal salt, salt substitute might reduce the risk of CVD death, especially stroke among hypertensive patients. Our exploratory follow-up results provide potential evidence that low-sodium salt may be an accessible and effective strategy for prevention of CVD events, but definitive randomized controlled trials are warranted.

Dialectical Behavior Therapy

2010 ◽  
pp. 401-416
Author(s):  
Eunice Y. Chen ◽  
Debra Safer
Keyword(s):  
Eating Disorders ◽  
Randomized Controlled Trial ◽  
Behavior Therapy ◽  
Dialectical Behavior Therapy ◽  
Research Evidence ◽  
Controlled Trial ◽  
Borderline Personality ◽  
Randomized Controlled ◽  
Promising Treatment ◽  
Trial Evidence

This chapter provides a description and reviews the research evidence for the adaptation of Dialectical Behavior Therapy (DBT) for eating disorders (EDs). First, the chapter briefly describes the standard DBT program as originally developed for women with borderline personality disorder (BPD). Second, the rationale for the adaptation of DBT for EDs is reviewed. Third, the DBT model of maintenance and etiology of EDs is discussed. Fourth, the randomized controlled trial evidence for DBT for BPD is reviewed as well as that for DBT for EDs. Finally, the DBT program for EDs is outlined. It is concluded that DBT is a promising treatment for EDs, worthy of further investigation with this population.

Sign in / Sign up

Export Citation Format

Share Document